Showing results (11-20 of 227) with videos related to
Sort By:
Pageof 23
Toxicon : Official Journal of the International Society on Toxinology|October 7, 2015
Is it time for flexibility in botulinum inter-injection intervals?Oluwadamilola O Ojo, Hubert H FernandezDrugs & Aging|July 31, 2008
Pathophysiology and treatment of psychosis in Parkinson's disease: a reviewLaura B Zahodne, Hubert H FernandezExpert Opinion on Investigational Drugs|March 22, 2006
Combating psychosis in Parkinson's disease patients: the use of antipsychotic drugsKelvin L Chou, Hubert H FernandezThe Neurologist|June 13, 2003
Classification and treatment of tardive syndromesHubert H Fernandez, Joseph H FriedmanJournal of the Neurological Sciences|January 21, 2017
Dopamine agonist withdrawal syndrome: A comprehensive reviewXin Xin Yu, Hubert H FernandezJournal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 16, 2013
Sustained benefit of painful legs moving toes syndrome with botulinum toxin type ARamon L Rodriguez, Hubert H FernandezCurrent Psychiatry Reports|September 16, 2016
Current Understanding of Psychosis in Parkinson's DiseaseOluwadamilola O Ojo, Hubert H FernandezDrugs & Aging|August 19, 2007
Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitorsJack J Chen, Hubert H FernandezPharmacotherapy|November 29, 2007
Monoamine oxidase-B inhibition in the treatment of Parkinson's diseaseHubert H Fernandez, Jack J ChenClinical Neuropharmacology|June 5, 2007
Monamine oxidase inhibitors: current and emerging agents for Parkinson diseaseHubert H Fernandez, Jack J ChenPageof 23